During HIV-1 encephalitis, the chemotaxis-inducing activity of Tat may enha
nce the viral life cycle through recruitment of additional susceptible micr
oglial cells to foci of infection. Benzodiazepines (BDZs) readily penetrate
the blood-brain barrier and are known to possess anti-inflammatory propert
ies. Pretreatment of human microglial cells with peripheral (Ro5-4864) and
mixed (diazepam), but not central (clonazepam), benzodiazepine receptor lig
ands was found to potently suppress HIV-1 Tat-induced chemotaxis. Applicati
on of Tat to microglial cells evokes an increase in intracellular calcium c
oncentration ([Ca2+](i)) that rapidly desensitizes the cells. Diazepam's in
hibitory effect was associated with its ability to block Tat-induced [Ca2+]
(i) mobilization. These data support the notion that through their effects
on microglia, peripheral BDZ receptor ligands could alter the neuropathogen
esis of HIV-1.